Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424051
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424051
Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global Antiparasitic Drugs market size is expected to reach USD 38.20 billion by 2032, according to a new study by Polaris Market Research. The report "Antiparasitic Drugs Market Share, Size, Trends, Industry Analysis Report, By Type (Antiprotozoals, Anthelmintics, Others); By Route of Administration; By Distribution Channel; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Emerging markets in developing regions offer prime opportunities for the Antiparasitic Drugs Market. Improved healthcare infrastructure and heightened awareness drive demand for effective treatments against parasitic infections. With higher infection rates in these regions, pharmaceutical companies introduce accessible and affordable solutions, establishing strategic collaborations for market entry and expansion.
Targeted therapies present a pivotal opportunity in the antiparasitic drugs market, offering precise, personalized treatment for enhanced efficacy and minimized side effects. Leveraging advancements in molecular understanding, these therapies focus on specific parasites, providing innovative solutions with improved patient outcomes. Pharmaceutical companies investing in research and development of such targeted approaches position themselves for market leadership. This strategic move addresses the challenges of drug resistance while expanding treatment options, aligning with the evolving landscape of personalized medicine in antiparasitic drug development.
Clinical trials play a pivotal role in shaping the antiparasitic drugs market. Beyond validating safety and efficacy, participation in rigorous trials positions pharmaceutical companies as innovators. Successful trials not only secure regulatory approvals but also establish credibility, gaining a competitive edge. This engagement fosters confidence among healthcare professionals, contributing to market growth. Furthermore, these trials broaden the spectrum of available treatment options, meeting evolving needs in the fight against parasitic infections and ensuring sustained market expansion.
Streamlined regulatory pathways, expedited approvals, and supportive frameworks create a conducive environment for pharmaceutical innovation. This backing allows companies to swiftly bring novel antiparasitic drugs to market, addressing critical healthcare needs. Collaborative efforts between regulatory bodies and industry players enable efficient processes, fostering timely market entry. The encouragement of innovative solutions, coupled with responsive regulatory frameworks, positions the antiparasitic drugs Market for sustained growth.
Antiparasitic Drugs Market Report Highlights
In 2023, the Anthelmintics segment accounted for significant market share owing to prevalence of helminthic infections, global health initiatives, and increased awareness.
In 2023, the injectable segment accounted for significant market share owing to rapid and direct response, and wide use in hospitals.
In 2023, the hospital pharmacy segment held significant revenue share owing to easy access for patients within healthcare institutions.
In 2023, North America region dominated the global market due to prevalence of parasitic infections, regulatory environment, and research and development.
The market is highly competitive owing to the existence of market players with a global presence, including Bayer AG, Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline, Ipca Laboratories Ltd, Merck & Co., Viatris, and Novartis among others.
Polaris Market Research has segmented the Antiparasitic Drugs market report based on type, route of administration, distribution channel, and region:
Antiparasitic Drugs, Type Outlook (Revenue - USD Billion, 2019 - 2032)
- Antiprotozoals
- Anthelmintics
- Others
Antiparasitic Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
- Topical
- Oral
- Injectable
Antiparasitic Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)
- Retail Pharmacy
- Hospital Pharmacy
- Others
Antiparasitic Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Indonesia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
Product Code: PM4409
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Antiparasitic Drugs Market Insights
- 4.1. Antiparasitic Drugs Market - Distribution Channel Snapshot
- 4.2. Antiparasitic Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Global health initiatives are projected to spur the product demand
- 4.2.1.2. Prevalence of parasitic infections is expected to drive antiparasitic drugs market growth
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory challenges are likely to impede the market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Antiparasitic Drugs Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Antiparasitic Drugs Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 5.3. Antiprotozoals
- 5.3.1. Global Antiparasitic Drugs Market, by Antiprotozoals, by Region, 2019-2032 (USD Billion)
- 5.4. Anthelmintics
- 5.4.1. Global Antiparasitic Drugs Market, by Anthelmintics, by Region, 2019-2032 (USD Billion)
- 5.5. Others
- 5.5.1. Global Antiparasitic Drugs Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Antiparasitic Drugs Market, by Route of Administration
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 6.3. Topical
- 6.3.1. Global Antiparasitic Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
- 6.4. Oral
- 6.4.1. Global Antiparasitic Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
- 6.5. Injectable
- 6.5.1. Global Antiparasitic Drugs Market, by Injectable, by Region, 2019-2032 (USD Billion)
7. Global Antiparasitic Drugs Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 7.3. Retail Pharmacy
- 7.3.1. Global Antiparasitic Drugs Market, by Retail Pharmacy, By Region, 2019-2032 (USD Billion)
- 7.4. Hospital Pharmacy
- 7.4.1. Global Antiparasitic Drugs Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Billion)
- 7.5. Others
- 7.5.1. Global Antiparasitic Drugs Market, by Others, By Region, 2019-2032 (USD Billion)
8. Global Antiparasitic Drugs Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Antiparasitic Drugs Market - North America
- 8.3.1. North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.3.2. North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.3. North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.4. Antiparasitic Drugs Market - U.S.
- 8.3.4.1. U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.3.5. Antiparasitic Drugs Market - Canada
- 8.3.5.1. Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4. Antiparasitic Drugs Market - Europe
- 8.4.1. Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.3. Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.4. Antiparasitic Drugs Market - UK
- 8.4.4.1. UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.5. Antiparasitic Drugs Market - France
- 8.4.5.1. France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.5.3. France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.6. Antiparasitic Drugs Market - Germany
- 8.4.6.1. Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.7. Antiparasitic Drugs Market - Italy
- 8.4.7.1. Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.8. Antiparasitic Drugs Market - Spain
- 8.4.8.1. Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.9. Antiparasitic Drugs Market - Netherlands
- 8.4.9.1. Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.4.10. Antiparasitic Drugs Market - Russia
- 8.4.10.1. Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5. Antiparasitic Drugs Market - Asia Pacific
- 8.5.1. Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.4. Antiparasitic Drugs Market - China
- 8.5.4.1. China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.4.3. China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.5. Antiparasitic Drugs Market - India
- 8.5.5.1. India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.5.3. India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.6. Antiparasitic Drugs Market - Malaysia
- 8.5.6.1. Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.7. Antiparasitic Drugs Market - Japan
- 8.5.7.1. Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.8. Antiparasitic Drugs Market - Indonesia
- 8.5.8.1. Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.5.9. Antiparasitic Drugs Market - South Korea
- 8.5.9.1. South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6. Antiparasitic Drugs Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.4. Antiparasitic Drugs Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.5. Antiparasitic Drugs Market - UAE
- 8.6.5.1. UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.6. Antiparasitic Drugs Market - Israel
- 8.6.6.1. Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.6.7. Antiparasitic Drugs Market - South Africa
- 8.6.7.1. South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7. Antiparasitic Drugs Market - Latin America
- 8.7.1. Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.4. Antiparasitic Drugs Market - Mexico
- 8.7.4.1. Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.5. Antiparasitic Drugs Market - Brazil
- 8.7.5.1. Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- 8.7.6. Antiparasitic Drugs Market - Argentina
- 8.7.6.1. Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AstraZeneca
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bayer AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Cipla Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Dr. Reddy's Laboratories
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. F. Hoffmann-La Roche Ltd
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Ipca Laboratories Ltd
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Lupin Pharmaceuticals
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Merck & Co.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Novartis
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Pfizer
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Sanofi
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Sun Pharmaceutical Industries Ltd.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Viatris
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Zydus Group
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
Product Code: PM4409
List of Tables
- Table 1 Global Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 2 Global Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 3 Global Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 4 Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 6 North America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 7 North America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 8 U.S.: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 9 U.S.: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 10 U.S.: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 11 Canada: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 12 Canada: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 13 Canada: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 14 Europe: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 15 Europe: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 16 Europe: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 17 UK: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 18 UK: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 19 UK: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 20 France: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 21 France: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 22 France: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 23 Germany: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 24 Germany: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 25 Germany: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 26 Italy: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 27 Italy: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 28 Italy: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 29 Spain: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 30 Spain: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 31 Spain: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 32 Netherlands: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 33 Netherlands: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 34 Netherlands: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 35 Russia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 36 Russia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 37 Russia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 41 China: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 42 China: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 43 China: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 44 India: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 45 India: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 46 India: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 47 Malaysia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 48 Malaysia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 49 Malaysia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 50 Japan: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 51 Japan: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 52 Japan: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 53 Indonesia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 54 Indonesia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 55 Indonesia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 56 South Korea: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 57 South Korea: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 58 South Korea: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 65 UAE: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 66 UAE: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 67 UAE: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 68 Israel: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 69 Israel: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 70 Israel: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 71 South Africa: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 72 South Africa: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 73 South Africa: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 74 Latin America: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 75 Latin America: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 76 Latin America: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 77 Mexico: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 78 Mexico: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 79 Mexico: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 80 Brazil: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 81 Brazil: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 82 Brazil: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
- Table 83 Argentina: Antiparasitic Drugs Market, by Type, 2019-2032 (USD Billion)
- Table 84 Argentina: Antiparasitic Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
- Table 85 Argentina: Antiparasitic Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Antiparasitic Drugs Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Route of Administration
- Figure 7. Global Antiparasitic Drugs Market, by Route of Administration, 2022 & 2032 (USD Billion)
- Figure 8. Market by Type
- Figure 9. Global Antiparasitic Drugs Market, by Type, 2022 & 2032 (USD Billion)
- Figure 10. Market by Distribution Channel
- Figure 11. Global Antiparasitic Drugs Market, by Distribution Channel, 2022 & 2032 (USD Billion)
- Figure 12. Antiparasitic Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Antiparasitic Drugs Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.